Tilfrinib
CAS: 1600515-49-8
Ref. 3D-APC51549
1mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen |
Produktinformation
Tilfrinib is a drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its kinase activity. It is an anti-EGFR antibody conjugate or immunoconjugate that is used for the treatment of cancers. The drug contains an antibody that binds to EGFR, which is linked to a cytotoxic agent such as a small molecule, toxin, or radioisotope. Tilfrinib has been shown to be effective in treating cancers with mutations in the EGFR gene.